NewsNational News

Actions

FDA says single-dose shot from J&J prevents severe COVID

Johnson & Johnson COVID-19 Vaccine
Posted
and last updated

ASSOCIATED PRESS — WASHINGTON (AP) — An analysis by U.S. regulators says Johnson & Johnson's single-dose vaccine provides strong protection against severe COVID-19. The report Wednesday confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. On Friday, a panel of experts to the Food and Drug Administration will debate if the evidence is strong enough to recommend the long-anticipated shot. The FDA is expected to make a final decision within days. If the FDA clears the J&J shot for U.S. use, it won’t boost vaccine supplies significantly right away. Only a few million doses are expected to be ready for shipping in the first week.

,

Weather

Daily Forecast

View Hourly Forecast

Day

Conditions

HI / LO

Precip

Tuesday

02/04/2025

Rain

-° / 48°

74%

Wednesday

02/05/2025

Mostly Clear

55° / 41°

8%

Thursday

02/06/2025

Showers Late

69° / 54°

36%

Friday

02/07/2025

Partly Cloudy

61° / 41°

10%

Saturday

02/08/2025

Partly Cloudy

58° / 40°

5%

Sunday

02/09/2025

Clear

58° / 37°

7%

Monday

02/10/2025

Partly Cloudy

58° / 37°

8%

Tuesday

02/11/2025

Partly Cloudy

59° / 38°

18%